查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1631560

女性健康體檢市場規模、佔有率、趨勢分析報告（按應用、最終用途和地區分類），2025 年至 2030 年

Women's Health Diagnostics Market Size, Share, & Trends Analysis Report By Application (Cancer, Infectious Disease, Osteoporosis), By End Use (Hospitals, Laboratory, Home Care), By Region, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

女性健康體檢市場的成長與趨勢：

根據 Grand View Research, Inc. 的一份新報告，到 2030 年全球女性健康診斷市場規模預計將達到 314.6 億美元。

預計 2025 年至 2030 年期間市場複合年成長率為 7.29%。照護現場的採用率不斷提高以及各種慢性病和文明病的盛行率不斷上升是推動市場成長的關鍵因素。此外，預計在預測期內各種宣傳計劃的推出也將有利於市場。例如，2014年歐盟委員會發起了「歐洲提高綜合癌症控制品質指南」聯合計劃。

隨著各機構資金投入的增加，婦女健康檢查呈現高速成長。例如，2015 年 5 月，Abcodia 獲得了 Cambridge Innovative Capital、Scottish Equity Partners 和 Albion Ventures 的資金，用於在英國推出卵巢癌風險演算法 (ROCA) 測試，以早期發現卵巢癌。的來自 UCLB 的資助。

根據最終用途，市場分為醫院和診斷中心以及家庭用途。由於醫院就診次數較多且檢測更可靠，醫院和診斷中心佔據了市場的大部分佔有率。

未來幾年亞太市場可能會大幅成長。市場的成長歸因於醫療保健投資的增加、國際設備製造商專注於加強其在該地區的銷售業務，以及該地區從感染疾病轉變為慢性病的流行病學日益增多。向

女性健康檢查市場報告重點

  • 政府和私人實體的投資增加以及可支配收入的提高正在推動市場的發展。
  • 2024年，癌症將佔據最大的市場佔有率。由於早期檢測測試的普及和政府對抗癌症的舉措，該領域在預測期內將實現顯著成長。
  • 由於產前疾病盛行率上升、母親年齡增加、醫療保健支出快速成長以及先進診斷測試的發展，產前檢測估計將成為這段時期成長最快的領域。
  • 按地區分類，北美將佔據市場主導地位，到 2024 年將佔據最大的收益佔有率，達到 46.21%。由於診斷和成像中心的基礎不斷擴大、癌症患者數量不斷增加、人們對不孕症檢測認知的不斷提高以及就地檢驗設備的廣泛使用，預計到 2030 年它將保持主導地位。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第 3 章女性健康篩檢變數、趨勢和範圍

  • 市場展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 女性健康檢查分析工具
    • 產業分析-波特五力分析
    • PESTEL 分析

4. 女性健康診斷市場：細分分析，按應用，2018 - 2030 年（百萬美元）

  • 定義和範圍
  • 2024 年和 2030 年應用市場佔有率分析
  • 女性健康體檢市場（按應用分類），2018 至 2030 年
  • 2018 年至 2030 年市場規模、預測與趨勢分析

5. 女性健康診斷市場：細分分析，依最終用途，2018 - 2030 年（百萬美元）

  • 定義和範圍
  • 2024 年及 2030 年最終用途市場佔有率分析
  • 2018 年至 2030 年全球女性健康診斷市場（依最終用途分類）
  • 2018 年至 2030 年市場規模、預測與趨勢分析

第6章：女性健康體檢市場：區域估計與趨勢分析

  • 區域控制面板
  • 市場規模、預測趨勢分析，2018-2030 年：
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭格局

  • 市場參與企業分類
  • 主要市場參與企業的近期趨勢及影響分析
  • 2024 年公司市場佔有率分析
  • 主要企業簡介
    • F. Hoffmann-La Roche Ltd.
    • Hologic, Inc.
    • Quest Diagnostics Incorporated
    • Abbott
    • BD
    • GE Healthcare
    • Koninklijke Philips NV
    • Aspira Women's Health
    • Thermo Fisher Scientific Inc.
    • Cardinal Health, Inc.
Product Code: GVR-2-68038-581-6

Women's Health Diagnostics Market Growth & Trends:

The global women's health diagnostics market size is expected to reach USD 31.46 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.29% from 2025 to 2030. Rising adoption of point-of-care diagnostics and growing incidence of various chronic and lifestyle diseases are among the key factors stimulating the growth of the market. Besides this, introducing various awareness programs is also anticipated to work in favor the market during the forecast period. For instance, in 2014, the European Commission launched joint action for European Guide on Quality Improvement in Comprehensive Cancer Control.

Women's health diagnostics is witnessing high growth due to increased funding from various organizations. For instance, in May 2015, Abcodia received funding of USD 8.0 million from Cambridge Innovative Capital, Scottish Equity Partners, Albion Ventures, and UCLB to launch Risk of Ovarian Cancer Algorithm (ROCA) test in the U.K. for early detection of ovarian cancer.

On the basis of end use, the market has been bifurcated into hospital & diagnostics centers and home. Hospitals and diagnostic centers accounted for a larger share in the market due to high number of visits to hospitals and more reliable detection.

The market in Asia Pacific is likely to witness significant growth over the coming years. The growth of the market can be attributed to increasing investments in healthcare, growing focus of international device manufacturers on strengthening their distribution networks within the region, and epidemiological shift from infectious diseases to chronic diseases within regional boundaries.

Women's Health Diagnostics Market Report Highlights:

  • Increasing investments by governments and private bodies and rising disposable income are providing a push to the market
  • Cancer accounted for the highest share in the market in 2024. The segment will register noteworthy growth during the forecast period owing to availability of early detection tests and government initiatives to tackle cancer
  • Prenatal testing is estimated to be the fastest growing segment during the same period owing to rising prevalence of prenatal diseases, increasing maternal age, surging healthcare expenditure, and development of advanced diagnostic tests
  • Geographically, North America dominated the market and accounted for the largest revenue share of 46.21% in 2024. It is anticipated to maintain its dominance through 2030, thanks to widening base of diagnostic and imaging centers, mounting cases of cancer, growing awareness about fertility testing, and spiraling adoption of point-of-care testing devices

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Application
    • 1.2.2. End Use
    • 1.2.3. Regional Scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Women's Health Diagnostics Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising prevalence of various health conditions in women
      • 3.2.1.2. Growing women health awareness,
      • 3.2.1.3. Technological advancements in diagnostics equipment
      • 3.2.1.4. Aging women population
      • 3.2.1.5. Developing global healthcare infrastructure
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Lack of access of diagnostic solutions
      • 3.2.2.2. High cost of diagnostic solutions
  • 3.3. Women's Health Diagnostics Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Women's Health Diagnostics Market: Segment Analysis, By Application, 2018 - 2030 (USD Million)

  • 4.1. Definition and Scope
  • 4.2. Application Market Share Analysis, 2024 & 2030
  • 4.3. Women's Health Diagnostics Market, by Application, 2018 to 2030
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 4.4.1. Cancer
      • 4.4.1.1. Cancer market, 2018 - 2030 (USD Million)
    • 4.4.2. Infectious diseases
      • 4.4.2.1. Infectious diseases market, 2018 - 2030 (USD Million)
    • 4.4.3. Osteoporosis
      • 4.4.3.1. Osteoporosis market, 2018 - 2030 (USD Million)
    • 4.4.4. Pregnancy & fertility
      • 4.4.4.1. Pregnancy & fertility market, 2018 - 2030 (USD Million)
    • 4.4.5. Prenatal
      • 4.4.5.1. Prenatal market, 2018 - 2030 (USD Million)

Chapter 5. Women's Health Diagnostics Market: Segment Analysis, By End Use, 2018 - 2030 (USD Million)

  • 5.1. Definition and Scope
  • 5.2. End Use Market Share Analysis, 2024 & 2030
  • 5.3. Global Women's Health Diagnostics Market, by End Use, 2018 to 2030
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 5.4.1. Hospitals
      • 5.4.1.1. Hospitals market, 2018 - 2030 (USD Million)
    • 5.4.2. Laboratory
      • 5.4.2.1. Laboratory market, 2018 - 2030 (USD Million)
    • 5.4.3. Home care
      • 5.4.3.1. Home care market, 2018 - 2030 (USD Million)
    • 5.4.4. Others
      • 5.4.4.1. Others market, 2018 - 2030 (USD Million)

Chapter 6. Women's Health Diagnostics Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Dashboard
  • 6.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.3. North America
    • 6.3.1. U.S.
      • 6.3.1.1. Key country dynamics
      • 6.3.1.2. Regulatory framework/ reimbursement structure
      • 6.3.1.3. Competitive scenario
      • 6.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.2. Canada
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Regulatory framework/ reimbursement structure
      • 6.3.2.3. Competitive scenario
      • 6.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.3. Mexico
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. Regulatory framework/ reimbursement structure
      • 6.3.3.3. Competitive scenario
      • 6.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Key country dynamics
      • 6.4.1.2. Regulatory framework/ reimbursement structure
      • 6.4.1.3. Competitive scenario
      • 6.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework/ reimbursement structure
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. France
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework/ reimbursement structure
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Regulatory framework/ reimbursement structure
      • 6.4.4.3. Competitive scenario
      • 6.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. Regulatory framework/ reimbursement structure
      • 6.4.5.3. Competitive scenario
      • 6.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.6. Norway
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Regulatory framework/ reimbursement structure
      • 6.4.6.3. Competitive scenario
      • 6.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Key country dynamics
      • 6.4.7.2. Regulatory framework/ reimbursement structure
      • 6.4.7.3. Competitive scenario
      • 6.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Key country dynamics
      • 6.4.8.2. Regulatory framework/ reimbursement structure
      • 6.4.8.3. Competitive scenario
      • 6.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. China
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. Japan
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.3. India
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework/ reimbursement structure
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.5. South Korea
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework/ reimbursement structure
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.6. Thailand
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework/ reimbursement structure
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. MEA
    • 6.6.1. South Africa
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Saudi Arabia
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.3. UAE
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.4. Kuwait
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework/ reimbursement structure
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Market Participant Categorization
  • 7.2. Recent Developments & Impact Analysis by Key Market Participants
  • 7.3. Company Market Share Analysis, 2024
  • 7.4. Key Company Profiles
    • 7.4.1. F. Hoffmann-La Roche Ltd.
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Hologic, Inc.
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. Quest Diagnostics Incorporated
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. Abbott
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Product benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. BD
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Product benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. GE Healthcare
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Product benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. Koninklijke Philips N.V.
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Product benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. Aspira Women's Health
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Product benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. Thermo Fisher Scientific Inc.
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Product benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. Cardinal Health, Inc.
      • 7.4.10.1. Company overview
      • 7.4.10.2. Financial performance
      • 7.4.10.3. Product benchmarking
      • 7.4.10.4. Strategic initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviation
  • Table 3. North America women's health diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 4. North America women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 5. North America women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 6. U.S. women's health diagnostics, by application, 2018 - 2030 (USD Million)
  • Table 7. U.S. women's health diagnostics, by end use, 2018 - 2030 (USD Million)
  • Table 8. Canada women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 9. Canada women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 10. Mexico women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 11. Mexico women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 12. Europe women's health diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 13. Europe women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 14. Europe women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 15. UK women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 16. UK women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 17. Germany women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 18. Germany women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 19. France women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 20. France women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 21. Italy women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 22. Italy women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 23. Spain women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 24. Spain women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 25. Norway women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 26. Norway women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 27. Sweden women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 28. Sweden women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 29. Denmark women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 30. Denmark women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 31. Asia Pacific women's health diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 32. Asia Pacific women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 33. Asia Pacific women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 34. China women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 35. China women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 36. Japan women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 37. Japan women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 38. India women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 39. India women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 40. Australia women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 41. Australia women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 42. South Korea women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 43. South Korea women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 44. Thailand women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 45. Thailand women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 46. Latin America women's health diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 47. Latin America women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 48. Latin America women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 49. Brazil women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 50. Brazil women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 51. Argentina women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 52. Argentina women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 53. Colombia women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 54. Colombia women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 55. Middle East & Africa women's health diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 56. Middle East & Africa women's health diagnostics, by bag usage, 2018 - 2030 (USD Million)
  • Table 57. Middle East & Africa women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 58. South Africa women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 59. South Africa women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 60. Saudi Arabia women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 61. Saudi Arabia women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 62. UAE women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 63. UAE women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 64. Kuwait women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 65. Kuwait women's health diagnostics market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Women's health diagnostics market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market outlook (2024)
  • Fig. 10 Segment Outlook
  • Fig. 11 Strategy framework
  • Fig. 12 Penetration & growth prospect mapping
  • Fig. 13 Market driver relevance analysis (Current & future impact)
  • Fig. 14 Market restraint relevance analysis (Current & future impact)
  • Fig. 15 Porter's five forces analysis
  • Fig. 16 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 17 Women's health diagnostics market: Application movement analysis
  • Fig. 18 Women's health diagnostics market application outlook: Key takeaways
  • Fig. 19 Cancer market, 2018 - 2030 (USD Million)
  • Fig. 20 Infectious diseases market, 2018 - 2030 (USD Million)
  • Fig. 21 Osteoporosis market, 2018 - 2030 (USD Million)
  • Fig. 22 Pregnancy & fertility market, 2018 - 2030 (USD Million)
  • Fig. 23 Prenatal market, 2018 - 2030 (USD Million)
  • Fig. 24 Women's health diagnostics market: End Use movement analysis
  • Fig. 25 Women's health diagnostics market end use outlook: Key takeaways
  • Fig. 26 Hospitals market, 2018 - 2030 (USD Million)
  • Fig. 27 Laboratory market, 2018 - 2030 (USD Million)
  • Fig. 28 Home care market, 2018 - 2030 (USD Million)
  • Fig. 29 Others market, 2018 - 2030 (USD Million)
  • Fig. 30 Regional outlook, 2019 & 2027
  • Fig. 31 Regional market place: Key takeaways
  • Fig. 32 North America, SWOT, by PEST
  • Fig. 33 Europe, SWOT, by PEST
  • Fig. 34 Asia Pacific, SWOT, by PEST
  • Fig. 35 Latin America, SWOT, by PEST
  • Fig. 36 Middle East and Africa,, SWOT, by PEST
  • Fig. 37 North America women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 38 US women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 39 Canada women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 40 Mexico women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 41 Europe women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 42 UK women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 43 Germany women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 44 France women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 45 Italy women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 46 Spain women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 47 Norway women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 48 Denmark women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 49 Sweden women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 50 Asia Pacific women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 51 Japan women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 52 China women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 53 India women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 54 Australia women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 55 South Korea women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 56 Thailand women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 57 Latin America women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 58 Brazil women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 59 Argentina women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 60 MEA women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 61 South Africa women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 62 Saudi Arabia women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 63 UAE women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 64 Kuwait women's health diagnostics market, 2018 - 2030 (USD Million)